Nancy Perley
Nurse Practitioner · Lakewood, CANPI 1295188282
Payments from drug & device makers
Across 273 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$977
- Dexcom, Inc.$953
- Bayer$805
- Novo Nordisk$706
- Mannkind Corporation$432
- Amgen$336
- plus $2K from 24 others
What the payments were for
- Travel & lodging$20%
- Food & beverage$5,93899%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 41 | $977 |
| Dexcom, Inc. | 51 | $953 |
| Bayer | 35 | $805 |
| Novo Nordisk | 43 | $706 |
| Mannkind Corporation | 14 | $432 |
| Amgen(2 entities) | 16 | $336 |
| Abbott | 13 | $284 |
| Sanofi-aventis U.S. LLC | 10 | $234 |
| Corcept Therapeutics | 3 | $150 |
| AstraZeneca | 6 | $116 |
| Insulet Corporation | 5 | $115 |
| Xeris Pharmaceuticals, Inc. | 5 | $108 |
| BD | 3 | $99 |
| Bigfoot Biomedical Inc | 3 | $90 |
| Cequr Corporation | 2 | $78 |
| Vistapharm, Inc. | 3 | $57 |
| BETA Bionics, Inc. | 2 | $46 |
| Amarin Pharma, Inc. | 2 | $42 |
| Tolmar, Inc. | 2 | $40 |
| Medtronic | 2 | $39 |
| Amphastar Pharmaceuticals, Inc. | 2 | $36 |
| Ionis Pharmaceuticals, Inc. | 1 | $33 |
| Radius Health, Inc. | 1 | $31 |
| Alvogen Inc | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| AbbVie | 1 | $26 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $20 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$363
- AFREZZA$250
- MOUNJARO$234
- DEXCOM G6 TRANSMITTER$107
How this compares
$5,975 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 271 | $267,977 |
| TrulicityDulaglutide | 117 | $136,589 |
| MounjaroTirzepatide | 121 | $130,960 |
| JanuviaSitagliptin Phosphate | 123 | $117,587 |
| TradjentaLinagliptin | 87 | $98,848 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 106 | $85,830 |
| JardianceEmpagliflozin | 74 | $84,123 |
| FarxigaDapagliflozin Propanediol | 81 | $72,285 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 57 | $71,188 |
| KerendiaFinerenone | 36 | $44,142 |
| Tresiba Flextouch U-100Insulin Degludec | 46 | $41,653 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 166 | $28,065 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $23,201 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 16 | $21,586 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 16 | $15,908 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $706 | $267,977271 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $977 | $267,549238 claims |
| Boehringer IngelheimTradjenta, Jardiance, Synjardy Xr | $26 | $191,233173 claims |
| MerckJanuvia | $16 | $117,587123 claims |
| AstraZenecaFarxiga | $116 | $72,28581 claims |
| BayerKerendia | $805 | $44,14236 claims |
| AbbVieSynthroid | $26 | $5,48253 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Lakewood
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.